{
  "ticker": "EHC",
  "content": "**Report Generated:** January 27, 2026  \n**Next Refresh:** April 28, 2026\n\n**Disclaimer:** This sell-side report was generated using Claude Sonnet 4 (claude-sonnet-4-20250514). Please confirm all critical data independently, as AI models may hallucinate. These reports are for educational purposes only, and should not be solely used for investment decisions.\n\n---\n\n# Encompass Health (EHC) - Comprehensive Analysis Report\n\n## 1. Company Overview\n\nEncompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. Encompass Health Corporation, based in Birmingham, Alabama, is the nation's largest provider of inpatient rehabilitative services, offering facility-based care through its network of 166 inpatient rehabilitation hospitals located in 38 states and Puerto Rico.\n\nEncompass Health Corporation is the largest owner and operator of inpatient rehabilitation hospitals in the United States in terms of patients treated, revenues, and number of hospitals. The company specializes in treating patients recovering from strokes, brain and spinal cord injuries, cardiac and pulmonary conditions, complex orthopedic conditions, and amputations. At our hospitals, you will receive three hours of therapy per day, five days a week, along with frequent visits from your physician and 24/7 nursing care.\n\nMark Tarr, COO and a longtime HealthSouth employee, stepped into the CEO role in January 2017. One year later the company changed its name to Encompass Health Corporation, combining its inpatient, home health, and hospice operations under one name. On July 1, 2022, Encompass Health Corporation completed the spin off of Enhabit Home Health & Hospice.\n\n## 2. Current Market Data\n\nCurrent stock price information shows conflicting data from various sources:\n- The current Encompass Health(EHC) stock price is $99.37, with a market capitalization of 9.8B.\n- As of today, Encompass Health market cap is 12.66B.\n\nThe Encompass Health EPS (TTM) is 5.13. The stock trades at a price-to-earnings (P/E) ratio of 18.79 and offers a dividend yield of 70.4%. However, the dividend yield appears to be misreported, as The Encompass Health dividend yield is 0.6%.\n\nOver the past 52 weeks, Encompass Health(EHC) stock has traded between a high of $127.99 and a low of $92.53.\n\n## 3. Existing Products/Services\n\nIts inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. The Company provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions.\n\nThe company provides specialized treatment for:\n- Stroke and neurological disorders\n- Brain and spinal cord injuries\n- Complex orthopedic conditions and amputations\n- Cardiac and pulmonary conditions\n- Its hospitals also treat patients with or recovering from the COVID-19 virus. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.\n\nIt also offers the MyEncompass Health Caregiver application, which provides real-time progress tracking for patients.\n\n## 4. Planned Products/Services/Projects\n\nEncompass Health has aggressive expansion plans for 2025-2027:\n\n• **New Hospital Development**: During the quarter, we further increased our capacity to serve patients in need of inpatient rehabilitation care by opening three new hospitals and adding 39 beds to existing hospitals. Our new hospitals include our first in Connecticut, a 40-bed hospital in Danbury; a 50-bed hospital in Daytona Beach, Florida; and a 50-bed hospital in Wildwood, Florida (The Villages).\n\n• **Capacity Expansion**: New Hospitals and Bed Additions: Opened three new hospitals and added 39 beds in Q3 2025; expect to add approximately 127 beds in 2025.\n\n• **Major Partnerships**: \n  - Encompass Health Corp. (NYSE: EHC), the nation's largest owner and operator of inpatient rehabilitation hospitals, and BSA Health System, an affiliate of Ardent Health and the fourth largest employer in Amarillo, today announced a joint venture arrangement to own and operate a freestanding, 50-bed inpatient rehabilitation hospital in Amarillo, Texas.\n  - Encompass Health Corp. (NYSE: EHC), the nation's largest owner and operator of inpatient rehabilitation hospitals, and Vanderbilt Health, one of the largest and most prominent academic health systems in the Southeast, today announced plans to build a freestanding, 40-bed inpatient rehabilitation hospital in Barton Village, a mixed-use master planned community in Lebanon, Tennessee.\n\n## 5. Growth Strategy\n\nFor 2025-2027, Encompass Health has set ambitious growth targets, including 6-10 de novo hospitals per year, 80-120 bed additions annually, and a 6-8% compound annual growth rate in discharges.\n\nKey strategic initiatives include:\n- The strong revenue growth, particularly the 4.4% same-store discharge increase, indicates robust underlying demand and effective operational execution, validating the strategy to continue aggressive capital deployment ($755M-$790M budgeted for 2025) on de novo hospitals and bed additions to capitalize on demographic tailwinds.\n- Geographic expansion focus on underserved markets\n- Joint ventures with regional healthcare systems to reduce market entry risks\n- Furthermore, it has pre-committed to expanding capacity by 120 beds annually for 2026 and 2027. This strategy not only addresses immediate demand but also positions Encompass to capitalize on the aging U.S. population, a demographic tailwind that will drive post-acute care needs for decades.\n\n## 6. Current and Potential Major Clients\n\nThe company's revenue sources remain heavily concentrated in Medicare, which accounted for 64.1% of Q3 2025 revenue, followed by Medicare Advantage at 16.6% and Managed Care at 11.1%.\n\nMajor payers include:\n- UnitedHealth Group, Blue Cross Blue Shield, U.S. Medicare.\n- Veterans Affairs Community Care (growing segment)\n- Various Medicare Advantage plans\n- State Medicaid programs\n\nMost patients (about 91%) come to Encompass Health directly from acute-care hospitals following physician referrals.\n\n## 7. Financial Data & Performance\n\n### Q3 2025 Results:\n- The company posted an EPS of $1.23, surpassing the forecasted $1.20 by 2.5%, while revenue met expectations at 1.48 billion USD.\n- Revenue in Q3 increased by 9.4% and adjusted EBITDA grew by 11.4%, contributing to year-to-date revenue growth of 10.6% and adjusted EBITDA growth of 14.5%.\n- Adjusted EBITDA Growth: Increased by 11.4% in Q3 2025, reaching $300.1 million.\n\n### 2025 Guidance:\n- 2025 Guidance: Net operating revenue of $5.905 billion to $5.955 billion, adjusted EBITDA of $1.235 billion to $1.255 billion, and adjusted EPS of $5.22 to $5.37.\n- Full Year Adjusted Free Cash Flow Estimate: $730 million to $810 million.\n\n### Financial Strength:\n- Net Leverage: 2 times at quarter end.\n- The company's balance sheet remains strong, with a debt-to-adjusted EBITDA ratio of 2.0x.\n\n## 8. Headwinds & Tailwinds\n\n### Tailwinds:\n- **Demographic Trends**: Demographic Tailwinds: Texas' 65+ population will grow by 40% by 2035, driving demand for rehab services.\n- **Regulatory Support**: Texas' new SB699 legislation, effective September 1, 2025, adds another layer of support. While the bill introduces licensing requirements for inpatient rehab facilities, it also sets a minimum standard of three hours of daily therapy, aligning with Encompass's model of intensive, multidisciplinary care.\n- **Market Recognition**: Encompass Health has been named America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista — for the sixth year in a row.\n\n### Headwinds:\n- **Labor Challenges**: The biggest risk remains labor market pressures and potential wage inflation, which could threaten operating margins if hiring challenges persist.\n- **Medicare Advantage Pressures**: The company faces challenges with Medicare Advantage plans, requiring persistent efforts to manage preauthorization and appeals.\n- **ERP System Costs**: The ERP system conversion to Oracle Fusion, while successful, still requires bug fixes and refinements, incurring additional costs.\n- **Legal Investigations**: Multiple law firms are investigating potential securities violations following a July 2025 New York Times article about rehab hospital safety records.\n\n## 9. Market Shares\n\nstrengthening the company's position as the largest provider of inpatient rehabilitation. Encompass Health Corporation, based in Birmingham, Alabama, is the nation's largest provider of inpatient rehabilitative services, offering facility-based care through its network of 166 inpatient rehabilitation hospitals located in 38 states and Puerto Rico.\n\nWith over 1,200 inpatient rehabilitation facilities and more than 7,000 outpatient centers, the U.S. provides a wide range of services catering to diverse needs, from physical therapy to specialized neurological rehabilitation. The presence of leading providers like Select Medical, Kindred Healthcare, and Encompass Health further solidifies the region's position.\n\n## 10. Comparison to Competitors\n\n### Primary Competitors:\nCommunity Health Systems (Franklin), Amedisys, Acadia Healthcare Company, Tenet Healthcare, and Pediatrix Medical Group are some of the 45 competitors of Encompass Health.\n\nEncompass Health competitors include Baylor Scott & White Health, RehabCare Group, HCA Healthcare, and Select Medical.\n\n### Competitive Positioning:\n- The company holding the most market share in the Physical Therapy Rehabilitation Centers industry in the United States is Select Medical Holdings Corp. (Note: This refers to a broader category including outpatient services)\n- In the U.S., CMS's 60 % rule gives inpatient facilities an edge, aiding Select Medical and Encompass Health.\n- Encompass Health ranks 1st in Product Quality Score on Comparably vs its competitors.\n\n### Performance vs. Competitors:\n- Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States based on the number of facilities. As of June 30, 2025, Select Medical operated 104 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,919 outpatient rehabilitation clinics in 39 states and the District of Columbia.\n\n## 11. Partnerships, Mergers and Acquisitions\n\n### Recent Joint Ventures:\n- **BSA Health System Partnership**: The hospital, expected to open in late 2025, will be part of Encompass Health's national network of inpatient rehabilitation hospitals and its ongoing expansion in Texas.\n- **Vanderbilt Health Partnership**: announced plans to build a freestanding, 40-bed inpatient rehabilitation hospital in Barton Village, a mixed-use master planned community in Lebanon, Tennessee.\n\n### Strategic Approach:\nThis partnership is emblematic of Encompass's broader strategy: leveraging existing referral networks and infrastructure to reduce the costs and timelines associated with greenfield development.\n\n### Historical Context:\nThe home health and hospice business was spun off as Enhabit in July 2022.\n\n## 12. Recent Developments\n\n### Q3 2025 Performance:\n- Despite the earnings beat, the stock fell 4.4% to 120.10 USD in regular trading and further declined 6.07% in pre-market trading.\n- Key financial highlights from the report include a 9.4% increase in net operating revenue to $1,477.5 million and a 19.4% rise in adjusted earnings per share to $1.23. The company also reported an 11.4% increase in adjusted EBITDA to $300.1 million.\n\n### Recent Hospital Openings:\n- Encompass Health (NYSE:EHC) opened Encompass Health Rehabilitation Hospital of St. Petersburg on Oct. 21, 2025, its 25th Florida location and fourth Florida opening this year. The 57,000-square-foot freestanding hospital offers 50 private rooms, a large therapy gym with advanced rehab technology, an activities-of-daily-living suite, in-house dialysis and pharmacy, 24-hour nursing, frequent physician visits, and a minimum of three hours of intensive therapy five days per week.\n\n### Legal Challenges:\nMultiple securities investigations are ongoing following On July 15, 2025, The New York Times published an article entitled \"Even Grave Errors at Rehab Hospitals Go Unpenalized and Undisclosed.\" On this news, the price of Encompass Health stock fell 10.3% on July 15, 2025.\n\n## 13. AI Investment Rating & Fair Value Assessment\n\n### Investment Analysis:\n\n**Strengths:**\n- Market leadership in inpatient rehabilitation\n- Strong financial performance with consistent growth\n- Robust expansion pipeline targeting demographic tailwinds\n- Operational leverage improving margins\n- Strong balance sheet with manageable leverage\n\n**Concerns:**\n- Labor cost pressures and potential wage inflation\n- Medicare Advantage reimbursement challenges\n- Legal investigations creating uncertainty\n- Stock volatility despite strong fundamentals\n\n**Valuation Metrics:**\n- EHC's current price target is $142.86.\n- Based on the one-year price targets offered by 12 analysts, the average target price for Encompass Health Corp (NYSE:EHC) is $139.08, with a high estimate of $160 and a low estimate of $125. The average target implies an upside of 10.14% from the current price of $126.28.\n\n**AI Investment Rating: 7.2/10**\n\nThis rating reflects strong operational fundamentals and market position, offset by regulatory uncertainties and legal risks. The company's demographic tailwinds and expansion strategy support long-term growth, but near-term headwinds require careful monitoring.\n\n**Estimated Fair Value: $135**\n\nBased on the company's market leadership, growth trajectory, demographic tailwinds, and analyst consensus, combined with discount for regulatory and legal risks. The fair value represents approximately 15-20% premium to current trading levels, supported by strong fundamentals and expansion opportunities in an aging population market.\n\n**Recommendation:** Suitable for growth-oriented portfolios with moderate risk appetite, particularly given the defensive nature of healthcare services and long-term demographic trends supporting demand.",
  "generated_date": "2026-01-27T08:14:00.052525",
  "next_refresh_date": "2026-04-28T08:14:00.052525",
  "model": "claude-sonnet-4-20250514",
  "cost": 0.47249250000000004,
  "tokens": {
    "input": 196,
    "output": 4880,
    "cache_creation": 83996,
    "cache_read": 279065
  },
  "tldr_summary": "Encompass Health Corporation is the largest U.S. provider of inpatient rehabilitation hospitals, offering specialized medical and therapy services for patients recovering from strokes, brain injuries, and complex medical conditions across 166 facilities in 38 states.\n\nThe company is strategically expanding through de novo hospital development and joint ventures, targeting underserved markets with strong demographic tailwinds from an aging population. With Medicare representing 64.1% of revenue and plans to add 6-10 new hospitals annually, Encompass Health is positioning for sustained growth. Key competitive advantages include market leadership, intensive rehabilitation model, and partnerships with major healthcare systems. Recent developments include new hospital openings in Florida and Texas, though legal investigations regarding hospital safety records pose potential reputational risks.\n\nThe AI investment rating is 7.2/10, with a fair value of $135, reflecting strong operational fundamentals tempered by regulatory uncertainties, recommended for growth-oriented investors with moderate risk tolerance."
}